Biogaran competitive analysis

Latest publications and patents of Biogaran New

Explore the latest publications and patents granted to Biogaran, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Biogaran against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 9, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsH LUNDBECKMar 6, 2024
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 30, 2023
Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAApr 20, 2023
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISJan 13, 2023
Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJan 14, 2022
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 23, 2021
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 31, 2020
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENJan 17, 2020
Rapid Dissolution Formulation Of A Cinacalcet HclAMGENJan 17, 2020
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 17, 2020

Latest PTAB cases involving Biogaran

Discover the latest PTAB cases involving Biogaran, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Biogaran with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 9, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
BIOGARAN12 - - - Highly Aggressive
AMGEN8132811Defensive
BIOGEN MA - 51 - 7Non-Active
NOVARTIS6407 - 21Defensive